28 Jun 2018 12:16
RNS Number : 8788S
Immupharma PLC
28 June 2018
28 JUNE 2018
This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.
2018 ANNUAL GENERAL MEETING - ALL RESOLUTIONS PASSED
ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, held its AGM earlier today and is pleased to announce that all resolutions were duly passed.
-Ends-
For further information please contact: ImmuPharma PLC (www.immupharma.co.uk) | + 44 (0) 20 7152 4080 | Tim McCarthy, Chairman | | Lisa Baderoon, Head of Investor Relations Twitter: @immupharma | + 44 (0) 7721 413496 | | | Northland Capital Partners Limited (NOMAD & Joint Broker) David Hignell, Dugald Carlean, Jamie Spotswood, Corporate Finance Rob Rees, Corporate Broking | +44 (0)20 3861 6625 | Bryan, Garnier & Co. (Joint Broker) Phil Walker, Corporate Finance Dominic Wilson, Sales | +44 (0)20 7332 2500 |
|
| | |
| | | |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
RAGFMGZVNRLGRZG
Immupharma (IMM)